Explore Stanford technologies available for licensing:

Stanford scientists have discovered a previously unrecognized blood immune cell marker for osteoarthritis (OA) early detection.

Stanford researchers have identified a small set of genes that can be used to diagnose active tuberculosis (TB), distinguish active TB from latent TB or other diseases, and predict progression from latent to active TB months before conventional tests.

Stanford scientists have designed a passive and active polarization-insensitive grating coupler that enables consistent fiber-to-chip light coupling regardless of input polarization state.

Scientists in the De Lecea and Pauly labs optimized ultrasound waveforms that non-invasively modulate brain circuits in freely moving mice.

Stanford researchers have improved sensing capabilities by inventing a novel set of quantum-enhanced optical sensors at chip scale.

Stanford researchers have developed a system that assesses altered mental states in both human and animal subjects using neural biomarkers, allowing for repeatable cross-species studies of potential treatments for psychiatric and neurological disorders.

Researchers at Stanford have developed methods and compositions to provide inducible production of anti-inflammatory cytokines in mesenchymal stem cells (MSCs).

The Stanford team's invention of ferrite microwave window is a breakthrough in high-power microwave protection.

Stanford researchers Robert Lowsky and Samuel Strober have developed a strategy for maintaining normal graft function without immune suppression medication. Kidney transplant recipients require lifelong use of immunosuppressants to minimize rejection risk.

Researchers at Stanford developed a novel technique to induce persistent mixed hematopoietic cell chimerism in organ recipients to protect against organ graft rejection and increase immune tolerance.

Stanford scientists have developed a plant-derived zinc protoporphyrin (ZnPP) produced from legume hemoglobin, a breakthrough therapy candidate for treating neonatal jaundice.

Stanford researchers have developed a novel blood-based diagnostic platform that leverages circulating bacteriophage DNA (phage cfDNA) to enable sensitive and highly specific detection of both overt and subclinical bacterial infections, while effectively discriminating them fr

New publication! Read the inventors' newly published Cell Genomics article for this technology (2025): "A peptide display system identifies a potent mutant β-melanocyte-stimulating hormon

Stanford researchers have developed a novel technology using extracellular vesicles (EVs) to selectively suppress immune responses to AAV vectors, enabling safer and more effective gene therapy.

The Stanford team invented a self-configuring network (SCN) that makes large-scale quantum photonic systems practical.